Daily Oncology News

Farydak (panobinostat) now FDA-approved for multiple myeloma

Farydak (panobinostat) now FDA-approved for multiple myeloma

Drug is now sanctioned for people who have received at least two prior standard therapies.

ASCO: Testicular cancer history may indicate greater risk of developing prostate cancer

ASCO: Testicular cancer history may indicate greater risk of developing prostate cancer

Individuals who've had testicular cancer may be at increased risk for prostate cancer, but the overall risk is low, according to a study.

Post-cancer survival up for Americans, but disparities remain

Post-cancer survival up for Americans, but disparities remain

Study shows biggest improvements in post-cancer survival for people diagnosed between ages 50 and 64.

Women educated on overdiagnsosis are less likely to want mammogram

Women educated on overdiagnsosis are less likely to want mammogram

Risks and benefits of routine mammography continue to be debated, but educating women about the possibility of overdiagnosis from mammography screening may make some of them less likely to get the test.

Research finds no link between cancer and pimecrolimus

Research finds no link between cancer and pimecrolimus

Company-funded research followed nearly 7,500 children over 10 years, but established no increased cancer risk caused by the use of pimecrolimus (Elidel) cream to treat eczema in children.

Healthful lifestyle advice needed by cancer survivors

Healthful lifestyle advice needed by cancer survivors

Oncology care teams should provide more guidance on lifestyle change as part of survivorship care, according to recent research.

Considerable practice variation among surgeons in selecting patients for radical prostatectomy

Considerable practice variation among surgeons in selecting patients for radical prostatectomy

Variation was observed at a high-volume center when surgeons selected patients with low-risk prostate cancer to undergo radical prostatectomy, according to a study.

Observation used increasingly in younger men with prostate cancer

Observation used increasingly in younger men with prostate cancer

From 2004 to 2009, marked increase in observation among men with low-risk prostate cancer has been observed.

ASCO endorses ACS recommendations for prostate cancer survivor care

ASCO endorses ACS recommendations for prostate cancer survivor care

Guideline outlines recommended follow-up care for prostate cancer survivors

Patient involvement increases perception of cancer care quality

Patient involvement increases perception of cancer care quality

Patients who participate in their medical decisions have a better impression about their level of care, a new study suggests, but researchers still unclear as to whether shared decision-making results in better outcomes.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs